A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia-Reference-Cited by-同舟云学术

A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia

Published:2016-04-06 Issue:18 Volume:86 Page:1729-1735
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Hainque Elodie,Vidailhet Marie,Cozic Nathalie,Charbonnier-Beaupel Fanny,Thobois Stéphane,Tranchant Christine,Brochard Vanessa,Glibert Gérald,Drapier Sophie,Mutez Eugénie,Doe De Maindreville Anne,Lebouvier Thibaud,Hubsch Cécile,Degos Bertrand,Bonnet Cécilia,Grabli David,Legrand André-Pierre,Méneret Aurélie,Azulay Jean-Philippe,Bissery Anne,Zahr Noël,Clot Fabienne,Mallet Alain,Dupont Sophie,Apartis Emmanuelle,Corvol Jean-Christophe,Roze Emmanuel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference40 articles.

1. Myoclonus-dystonia: Clinical and electrophysiologic pattern related to SGCE mutations

2. Pallidal stimulation for myoclonus-dystonia: Ten years' outcome in two patients

3. SGCE mutations cause psychiatric disorders: clinical and genetic characterization

4. Cognition and psychopathology in myoclonus-dystonia

5. Myoclonus-dystonia: significance of largeSGCEdeletions

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Pathophysiological Mechanisms Underpinning Myoclonus Dystonia Using Pluripotent Stem Cell-Derived Cellular Models;Cells;2024-09-10

2. Emerging therapies for childhood-onset movement disorders;Current Opinion in Pediatrics;2024-04-04

3. Myoclonus-Dystonia Plus Syndrome With Early-Onset Multiple Cerebral Cavernous Malformation Type 1 and Growth Hormone Deficiency Associated With Novel 7q21.13-q21.3 Deletion: A Pediatric Case Report;Cureus;2024-03-16

4. Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study;Neurological Sciences;2024-02-20

5. Myoclonus;Movement Disorders Phenomenology;2024